Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP-AzeFlu Onset of Action in Seasonal Allergic Rhinitis
NCT03004131Phase 4Completed
- Sponsor
- Meda
- Start
- Jan 2017
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Meda. Primary endpoint: Total Nasal Symptom Score at 4 hours. Started Jan 2017; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03004131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004131.